Critical roles of T cells in idiopathic polymyositis have been suggested, but, those in polymyositis occurring as GVHD after BMT are poorly understood. We thus investigated T cell clonality in a patient with posttransplant polymyositis. As a result, T cell receptor ␤ chains used various BV families in peripheral blood, but only one BV family (BV7) in affected muscle. Importantly, T cells proliferated oligoclonally both in the peripheral blood and the muscle, however, the expanded clonotypes were completely different. Taken Idiopathic polymyositis (iPM) is a systemic chronic inflammatory disease, which is pathologically characterized by infiltration of inflammatory cells into skeletal muscle fibers and subsequent degeneration of the fibers. Although the precise cause of iPM is still unclear, activated CD8 + T lymphocytes infiltrating into the muscle are thought to attack the muscle tissue.
Idiopathic polymyositis (iPM) is a systemic chronic inflammatory disease, which is pathologically characterized by infiltration of inflammatory cells into skeletal muscle fibers and subsequent degeneration of the fibers. Although the precise cause of iPM is still unclear, activated CD8 + T lymphocytes infiltrating into the muscle are thought to attack the muscle tissue. 1 In fact, muscle-infiltrating T cells have been found to display oligoclonal accumulation, suggesting that T cells stimulated by as yet unidentified autoantigens of the muscle proliferated clonally. 2, 3 PM has been reported in approximately 30 long-term survivors with allogeneic bone marrow transplantion (BMT). This post-transplant PM (pPM) is considered as one of the manifestations of chronic graft-versus-host disease (cGVHD), since most of the patients with pPM were reported simultaneously to display cGVHD. 4, 5 cally, muscle specimens from patients with pPM show predominant infiltration of cytotoxic T cells. 6 This indicates that T cells attack muscle-specific antigens as speculated in the case of iPM. Clonotypic analyses of T cell receptors (TCR) on the muscle-infiltrating T cells would be a clue to estimate whether the T cells are antigen-specific or nonspecific, however, detailed analyses on the muscle-infiltrating T cells in pPM have not been available, mainly because of its rare occurrence.
Here, we had a chance to investigate TCR clonotypes of T cells in peripheral blood (PB) and affected muscle of a patient with pPM. As a result, the muscle-infiltrating T cells showed clonal expansion of only one TCR ␤ chain variable region (BV) family and the expanded T cell clonotypes were completely different from those in PB. Our findings suggest that T cells infiltrating the muscle of the patient with pPM recognize very limited antigens, probably specific for the muscle tissue.
A 38 year-old man with chronic myelogenous leukemia underwent allo-BMT from an HLA-matched unrelated donor. Cyclophosphamide (120 mg/kg) followed by total body irradiation (12 Gy in six fractions), standard-dose cyclosporin and a short course of methotrexate were used for prophylaxis of GVHD. On the 26th day after BMT, acute GVHD of grade II, involving the skin and the gastrointestinal tract, was documented. He has been treated with prednisolone and tacrolimus since then. One year after BMT, he was hospitalized again presenting myalgia and muscle weakness at the shoulders, neck and thighs. He had difficulty walking and rising from the sitting position. A serum level of creatinine phosphokinase (CPK) was 7390 IU/l (Ͻ169 IU/l). A biopsied sample of quadriceps muscle showed infiltration of inflammatory cells, multiple foci of single cell necrosis and degeneration of the muscle fibers. Based on the clinical course and the histological examination, the diagnosis of pPM was made. Based on these data, pPM was diagnosed and thus an increased amount of prednisolone was administered, which improved his symptoms dramatically in 2 days. Two weeks later, his serum CPK level became within the reference limit. He became able to walk without difficulty within 2 months. We investigated TCR clonotypes of T cells in the biopsied muscle and peripheral blood mononuclear cells (PBMCs) which were simultaneously obtained with informed consent. First, TCR ␤ genes of 20 BV families were individually amplified by the reverse transcriptasepolymerase chain reaction from PBMCs and from the muscle specimen, respectively. Then the BV family usage was determined by Southern blotting using a DNA probe for the constant region of TCR ␤ chain. 7 As a result, TCR ␤ gene products were amplified well in all the tested 20 TCR BV families in the PBMC sample (Figure 1 ), indicating the circulating T cells used a wide range of TCR BV families as in healthy people. In contrast, TCR BV gene products were detected only in the BV7 family from the muscle sample, indicating selected infiltration or proliferation of the BV7-carrying T cells in the affected muscle tissue ( Figure 1) .
Next, we tried to elucidate whether T cells expanded clonally or not by the SSCP method. 7 As a result, distinct bands indicating clonal accumulation of T cells were observed in all of the 20 tested BV families including BV7 in PBMC (Figure 2a) . The PCR products of TCR BV7-carrying genes from the biopsied muscle sample also migrated to form distinct bands on the SSCP gel, however, the pattern of the separated bands was quite different from that in PBMCs (Figure 2b) .
To investigate whether the accumulated T cell clonotypes in the muscle were identical to those in PBMC or not, we determined nucleotide sequences of the TCR BV7-carrying genes from each of the two samples. Nucleotide sequences and deduced amino acid sequences of randomly cloned 16 TCRBV CDR3 regions genes for each sample are described in Figure 3a . As shown, two and three expanded TCR clonotypes were found in the PBMC and the muscle results, respectively, but the expanded TCR clonotypes were completely different between the muscle tissue and PBMC. To determine whether these expanded T cell clonotypes found in muscle were completely specific for muscle, we performed Southern blotting of BV7-PCR products from healthy PBMCs, pPM-PBMCs and the pPM muscle, using the three DNA probes which corresponded to the TCR CDR3 regions of the expanded clonotypes in muscle (5Ј-CAAGTAGAAGGGTATG-3Ј for BV7-VEG-JB1.2, 5Ј-CAAGAGAACGGCTGG-3Ј for BV7-ENGW-JB2.7, and 5Ј-CGGGACGGCGGTTC-3Ј for BV7-LLPGRRFESF Jb1.2). As shown in Figure 3b , these probes hybridized to the PCR product of pPM-PBMCs very weakly. A densitometric analysis revealed that only about 4.6% of the three expanded clonotypes resided in the periphery. Interestingly, all of these three expanded T cell clonotypes in the muscle sample were found to carry an anionic amino acid, glutamic acid, in their CDR3 region, but the T cell clonotypes in PBMCs did not (Figure 3a) .
Taking these results together, T cell clonotypes accumu- regions. TCR BV7-carrying genes amplified from PBMC or a biopsied muscle sample from the pPM patient were cloned into plasmid vectors. Then, nucleotide sequences of 16 randomly selected clones were determined. (b) BV7-PCR products from healthy PBMCs, the pPM-PBMCs and the pPM-muscle were hybridized with a mixture of DNA probes that corresponded to the CDR3 regions of the three clonotypes expanded in the pPM muscle.
Bone Marrow Transplantation lated in the muscle tissue are extremely restricted to BV7 and different from those in PBMCs, although numerous T cell clonotypes were potentially available from PB. Similar restriction of the TCRBV usage of only BV3 family was reported in the muscle of patients with iPM. 8 Such restricted use of the BV family would reflect limited kinds of antigens including muscle-specific autoantigens or superantigens. However, the dominant TCR BVs reported were different from cohort to cohort. Further, oligoclonal T cell accumulation was reported recently in such dominant BV families of muscle infiltrates in cases of iPM. 2, 3, 9 Our results in pPM also detected oligoclonal T cell expansion. This indicates that involvement of the superantigens would be unlikely in both iPM and pPM. All the expanded TCR clonotypes in the muscle were characterized by possession of glutamic acid in their CDR3 regions, which were the main region of TCR for recognition of antigens. In this context, Mantegazza et al 9 reported that TCR ␤ chains of muscle-infiltrating T cells in cases of iPM frequently carried anionic amino acids of glutamic acid or aspartic acid in their CDR3 regions. Taken together, stimulating antigenic peptides derived from the muscle tissue may carry cationic amino acids both in the cases of iPM and pPM. From sequencing analysis the expanded T cell clonotypes in the BV7 were completely different between muscle and PBMCs as described above. The clonotypes expanded in muscle were present in PBMCs at very low frequency. This is in contrast to a previous study on iPM, in which about half of the expanded T cell clonotypes in PBMCs were detected as expanded ones in muscle. 10 The predominant accumulation of the three clonotypes in muscle in our case may indicate in situ proliferation. Further, T cell clonotypes may be more restricted in pPM than in iPM.
In conclusion, this is the first report to our knowledge to investigate T cell clonality in a patient with pPM. Our data indicate that very limited T cell clonotypes and limited antigens are responsible for the muscle disorder of pPM as speculated in iPM. Further studies are needed to confirm whether the clonal expansion of the limited T cells is a common phenomenon in pPM patients and to elucidate which antigen triggers the stimulation of such restricted T cells.
